STOCK TITAN

[Form 4] FIREFLY NEUROSCIENCE, INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Firefly Neuroscience (AIFF) insiders reported open‑market sales by a group affiliated with Windsor Private Capital. On 10/15/2025, 17,500 shares were sold at an average price of $2.7444; on 10/16/2025, 40,139 shares at $2.6522; and on 10/17/2025, 45,036 shares at $2.5462. Following these transactions, the group reported 1,452,701, then 1,412,562, and finally 1,367,526 shares beneficially owned. The filing notes these sales were conducted under Rule 144 and that the holdings are reported as indirectly owned through Windsor, with the reporting persons identified as members of a group that beneficially owns more than 10%.

Firefly Neuroscience (AIFF) insider hanno riferito vendite sul mercato aperto da un gruppo affiliato a Windsor Private Capital. Il 15/10/2025 sono state vendute 17.500 azioni a prezzo medio di $2.7444; il 16/10/2025, 40.139 azioni a $2.6522; e il 17/10/2025, 45.036 azioni a $2.5462. A seguito di queste operazioni, il gruppo ha riportato 1.452.701, poi 1.412.562, e infine 1.367.526 azioni possedute economicamente. La dichiarazione indica che queste vendite sono state effettuate ai sensi della Regola 144 e che le partecipazioni sono riportate come indirettamente possedute tramite Windsor, con le persone riportanti identificate come membri di un gruppo che detiene più del 10%.

Firefly Neuroscience (AIFF) insiders reportaron ventas en el mercado abierto por un grupo afiliado a Windsor Private Capital. El 15/10/2025 se vendieron 17.500 acciones a un precio medio de $2.7444; el 16/10/2025, 40.139 acciones a $2.6522; y el 17/10/2025, 45.036 acciones a $2.5462. Tras estas operaciones, el grupo reportó 1.452.701, luego 1.412.562, y finalmente 1.367.526 acciones beneficiosamente poseídas. El archivo señala que estas ventas se realizaron bajo la Regla 144 y que las participaciones se reportan como indirectamente poseídas a través de Windsor, con las personas reportantes identificadas como miembros de un grupo que posee más del 10%.

Firefly Neuroscience (AIFF) 내부 관계자들이 Windsor Private Capital에 제휴된 그룹의 공개시장 매도가 있었다고 보고했습니다. 2025년 10월 15일에는 17,500주가 평균가 $2.7444로 매도되었고; 2025년 10월 16일에는 40,139주가 $2.6522로, 2025년 10월 17일에는 45,036주가 $2.5462로 매도되었습니다. 이 거래들 이후, 해당 그룹은 차익을 포함한 소유 주식을 1,452,701주로 보고했고, 그 다음 1,412,562주, 그리고 마지막으로 1,367,526주를 보유하고 있다고 보고했습니다. 서류에 따르면 이 매매는 규칙 144에 따라 수행되었으며, Windsor를 통해 간접적으로 소유된 보유로 보고되며 보고인들은 10% 이상 보유하는 그룹의 구성원으로 식별됩니다.

Firefly Neuroscience (AIFF) des initiés auraient rapporté des ventes sur le marché libre par un groupe affilié à Windsor Private Capital. Le 15/10/2025, 17 500 actions ont été vendues au prix moyen de $2,7444; le 16/10/2025, 40 139 actions à $2,6522; et le 17/10/2025, 45 036 actions à $2,5462. Suite à ces transactions, le groupe a déclaré posséder 1 452 701 actions bénéficiaires, puis 1 412 562, et enfin 1 367 526. Le dossier indique que ces ventes ont été effectuées sous la Règle 144 et que les participations sont déclarées comme détenues indirectement via Windsor, les personnes déclarantes étant identifiées comme membres d’un groupe détenant plus de 10%.

Firefly Neuroscience (AIFF) Insideren meldeten Offenmarktverkäufe durch eine mit Windsor Private Capital verbundenen Gruppe. Am 15.10.2025 wurden 17.500 Aktien zu einem Durchschnittspreis von $2.7444 verkauft; am 16.10.2025 40.139 Aktien zu $2.6522; und am 17.10.2025 45.036 Aktien zu $2.5462. Nach diesen Transaktionen meldete die Gruppe 1.452.701 Aktien, dann 1.412.562, und schließlich 1.367.526 Aktien als wirtschaftlich Berechtigte. Die Einreichung vermerkt, dass diese Verkäufe unter der Rule 144 durchgeführt wurden und dass die Beteiligungen als indirekt über Windsor gehalten gemeldet werden, wobei die meldenden Personen als Mitglieder einer Gruppe identifiziert werden, die mehr als 10% besitzt.

Firefly Neuroscience (AIFF) أبلغ المطلعون عن مبيعات في السوق المفتوح من قبل مجموعة مرتبطة بـ Windsor Private Capital. في 15/10/2025، تم بيع 17,500 سهم بسعر متوسط $2.7444؛ وفي 16/10/2025، 40,139 سهمًا بسعر $2.6522؛ وفي 17/10/2025، 45,036 سهمًا بسعر $2.5462. عقب هذه المعاملات، أبلغت المجموعة عن ملكية مستفيدة قدرها 1,452,701، ثم 1,412,562، وأخيرًا 1,367,526 سهمًا. تشير الوثائق إلى أن هذه المبيعات تمت بموجب Rule 144 وأن الحيازات مذكورة كمالكة بشكل غير مباشر من خلال Windsor، ويُعرَف الأشخاص المبلّغ عنهم كأعضاء في مجموعة تملك أكثر من 10%.

Firefly Neuroscience (AIFF) 的内部人士报道称,与 Windsor Private Capital 有关联的一组在公开市场进行了出售。2025-10-15,卖出 17,500 股,平均价格为 $2.7444;2025-10-16,卖出 40,139 股,价格为 $2.6522;2025-10-17,卖出 45,036 股,价格为 $2.5462。在这些交易之后,该集团的受益所有权股票数为 1,452,701,随后是 1,412,562,最后是 1,367,526 股。 文件指出这些销售是在 Rule 144 下进行的,持股报告为通过 Windsor 间接持有,报告人被标识为拥有超过 10% 的集团成员。

Positive
  • None.
Negative
  • None.

Firefly Neuroscience (AIFF) insider hanno riferito vendite sul mercato aperto da un gruppo affiliato a Windsor Private Capital. Il 15/10/2025 sono state vendute 17.500 azioni a prezzo medio di $2.7444; il 16/10/2025, 40.139 azioni a $2.6522; e il 17/10/2025, 45.036 azioni a $2.5462. A seguito di queste operazioni, il gruppo ha riportato 1.452.701, poi 1.412.562, e infine 1.367.526 azioni possedute economicamente. La dichiarazione indica che queste vendite sono state effettuate ai sensi della Regola 144 e che le partecipazioni sono riportate come indirettamente possedute tramite Windsor, con le persone riportanti identificate come membri di un gruppo che detiene più del 10%.

Firefly Neuroscience (AIFF) insiders reportaron ventas en el mercado abierto por un grupo afiliado a Windsor Private Capital. El 15/10/2025 se vendieron 17.500 acciones a un precio medio de $2.7444; el 16/10/2025, 40.139 acciones a $2.6522; y el 17/10/2025, 45.036 acciones a $2.5462. Tras estas operaciones, el grupo reportó 1.452.701, luego 1.412.562, y finalmente 1.367.526 acciones beneficiosamente poseídas. El archivo señala que estas ventas se realizaron bajo la Regla 144 y que las participaciones se reportan como indirectamente poseídas a través de Windsor, con las personas reportantes identificadas como miembros de un grupo que posee más del 10%.

Firefly Neuroscience (AIFF) 내부 관계자들이 Windsor Private Capital에 제휴된 그룹의 공개시장 매도가 있었다고 보고했습니다. 2025년 10월 15일에는 17,500주가 평균가 $2.7444로 매도되었고; 2025년 10월 16일에는 40,139주가 $2.6522로, 2025년 10월 17일에는 45,036주가 $2.5462로 매도되었습니다. 이 거래들 이후, 해당 그룹은 차익을 포함한 소유 주식을 1,452,701주로 보고했고, 그 다음 1,412,562주, 그리고 마지막으로 1,367,526주를 보유하고 있다고 보고했습니다. 서류에 따르면 이 매매는 규칙 144에 따라 수행되었으며, Windsor를 통해 간접적으로 소유된 보유로 보고되며 보고인들은 10% 이상 보유하는 그룹의 구성원으로 식별됩니다.

Firefly Neuroscience (AIFF) des initiés auraient rapporté des ventes sur le marché libre par un groupe affilié à Windsor Private Capital. Le 15/10/2025, 17 500 actions ont été vendues au prix moyen de $2,7444; le 16/10/2025, 40 139 actions à $2,6522; et le 17/10/2025, 45 036 actions à $2,5462. Suite à ces transactions, le groupe a déclaré posséder 1 452 701 actions bénéficiaires, puis 1 412 562, et enfin 1 367 526. Le dossier indique que ces ventes ont été effectuées sous la Règle 144 et que les participations sont déclarées comme détenues indirectement via Windsor, les personnes déclarantes étant identifiées comme membres d’un groupe détenant plus de 10%.

Firefly Neuroscience (AIFF) Insideren meldeten Offenmarktverkäufe durch eine mit Windsor Private Capital verbundenen Gruppe. Am 15.10.2025 wurden 17.500 Aktien zu einem Durchschnittspreis von $2.7444 verkauft; am 16.10.2025 40.139 Aktien zu $2.6522; und am 17.10.2025 45.036 Aktien zu $2.5462. Nach diesen Transaktionen meldete die Gruppe 1.452.701 Aktien, dann 1.412.562, und schließlich 1.367.526 Aktien als wirtschaftlich Berechtigte. Die Einreichung vermerkt, dass diese Verkäufe unter der Rule 144 durchgeführt wurden und dass die Beteiligungen als indirekt über Windsor gehalten gemeldet werden, wobei die meldenden Personen als Mitglieder einer Gruppe identifiziert werden, die mehr als 10% besitzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIREFLY NEUROSCIENCE, INC. [ AIFF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/15/2025 S(2) 17,500 D $2.7444 1,452,701 I See footnote(3)
Common Stock(1) 10/16/2025 S(2) 40,139 D $2.6522 1,412,562 I See footnote(3)
Common Stock(1) 10/17/2025 S(2) 45,036 D $2.5462 1,367,526 I See footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC Management Services Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC GP I Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Kupinsky Jordan

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJRK Holdings Inc.

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJR Kupinsky 2013 Family Trust

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Marcello Rocco

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Cundari John

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This Form 4 is filed jointly by Windsor Private Capital LP ("Windsor"), WPC Management Services Inc. ("WPC Management Services"), WPC GP I Inc. ("WPC"), Jordan Kupinsky ("Mr. Kupinsky"), HJRK Holdings Inc. ("HJRK"), HJR Kupinsky 2013 Family Trust ("HJRK Trust"), Rocco Marcello ("Mr. Marcello") and John Cundari ("Mr. Cundari", and collectively, the "Reporting Persons"). The Reporting Persons are members of a "group" that beneficially owns more than 10% of the shares of common stock of Firefly Neurosciences, Inc. (the "Issuer").
2. These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended.
3. The reported securities are held directly by Windsor. Mr. Marcello is Founder, Chairman and Chief Executive Officer of Windsor. Mr. Cundari is President of Windsor. Mr. Kupinsky is Managing Partner of Windsor. WPC is the general partner of Windsor and WPC Management Services is the sole shareholder of WPC. Mr. Marcello, Mr. Cundari and Mr. Kupinsky are the directors of WPC and WPC Management Services. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari may be deemed to beneficially own the reported securities. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari disclaim beneficial ownership of the securities held directly by Windsor except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello or Mr. Cundari is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
Windsor Private Capital LP, by its General Partner, WPC GP I Inc., /s/ John Cundari, Partner 10/17/2025
WPC Management Services Inc., /s/ John Cundari, Partner 10/17/2025
WPC GP I Inc., /s/ John Cundari, Partner 10/17/2025
/s/ Jordan Kupinsky 10/17/2025
HJRK Holdings Inc., /s/ Jordan Kupinsky, President and Director 10/17/2025
HJR Kupinsky 2013 Family Trust, by its Trustee, Jordan Kupinsky, /s/ Jordan Kupinsky 10/17/2025
/s/ Rocco Marcello 10/17/2025
/s/ John Cundari 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AIFF’s Form 4 disclose?

Open‑market sales of common stock by a reporting group affiliated with Windsor Private Capital over three days, with updated beneficial ownership.

How many AIFF shares were sold and at what prices?

10/15: 17,500 at $2.7444; 10/16: 40,139 at $2.6522; 10/17: 45,036 at $2.5462.

What is the group’s beneficial ownership after the sales?

Reported beneficial ownership decreased to 1,367,526 shares after the 10/17/2025 transaction.

Were the AIFF insider sales under Rule 144?

Yes. The filing states the broker‑dealer sales were conducted in accordance with Rule 144.

Is the ownership direct or indirect?

Indirect. The reported securities are held by Windsor Private Capital LP; certain individuals and entities may be deemed beneficial owners as disclosed.

Who are the reporting persons on this Form 4?

Windsor Private Capital LP, WPC Management Services Inc., WPC GP I Inc., Jordan Kupinsky, HJRK Holdings Inc., HJR Kupinsky 2013 Family Trust, Rocco Marcello, and John Cundari.

What is the relationship to the issuer?

The reporting persons are identified as members of a group that beneficially owns more than 10%.
Firefly Neuroscience Inc.

NASDAQ:AIFF

AIFF Rankings

AIFF Latest News

AIFF Latest SEC Filings

AIFF Stock Data

35.37M
8.71M
38.52%
10.85%
13.28%
Software - Application
Services-prepackaged Software
Link
United States
KENMORE